Spastic Paraplegia, Hereditary: Clinical Trials

49 trials for Spastic Paraplegia, Hereditary, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

20 completed, 19 recruiting, 3 active not recruiting, 3 terminated. 15 Not applicable, 6 Phase 2, 3 Phase 1, 1 Early Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable15Recruiting 7, Completed 4, Active not recruiting 1, Enrolling by invitation 1, Unknown 1, Withdrawn 1
Phase 26Completed 4, Not yet recruiting 1, Terminated 1
Phase 13Completed 1, Not yet recruiting 1, Terminated 1
Early Phase 11Recruiting 1
Phase 31Completed 1
Phase 41Completed 1

Follow Spastic Paraplegia, Hereditary: new trials by email Literature Review of Spastic Paraplegia, Hereditary trials Research Report on Spastic Paraplegia, Hereditary

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rare Disease Registry Database for Movement Disorders in Southern Anhui Province
Motor Neuron Diseases, Spinocerebellar Ataxias
RecruitingFirst Affiliated Hospital of Wannan Medical College1802026-09-302026-10-23
Neuromodulation to Enhance Motor Function in HSP
transcutaneous spinal cord stimulation - Hereditary Spastic Paraplegia
Not applicableRecruitingRahul Sachdeva152026-04-092026-04-22
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Whole-body Electrical Muscle Stimulation Exercise - Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis
Not applicableRecruitingUniversity of Missouri-Columbia502026-03-102026-03-17
Dental-Oral and Craniofacial Characteristics of Hereditary Spastic Paraplegia: A Preliminary Study
Hereditary Spastic Paraplegia
CompletedUniversity of Barcelona502025-10-152026-09-02
Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47)
BFB-101 (AAV9-CBh-AP4B1) - HSP, Hereditary Spastic Paraplegia
Phase 1 / Phase 2Not yet recruitingBlackfinBio Ltd52025-08-012025-04-28
A Prospective Cohort Study of Surgical Treatment for Foot Deformities in HSP
Hereditary Spastic Paraplegia
RecruitingShanghai 6th People's Hospital1002025-03-012025-04-20
A Prospective Cohort Study of ITB Treatment for HSP
Hereditary Spastic Paraplegia
RecruitingShanghai 6th People's Hospital502025-01-012025-02-26
Flexibility, Resistance, Aerobic, Movement Execution Training in Adults With Hereditary Spastic Paraplegia
Flexibility, Resistance, Aerobic, Movement Execution training - Hereditary Spastic Paraplegia
Not applicableRecruitingIRCCS Eugenio Medea202024-12-232025-01-30
Enhancement of Quality of Work And Life
Preventive Participatory workplace intervention - Parkinson Disease, Hereditary Spastic Paraparesis
Not applicableActive not recruitingRadboud University Medical Center1242024-10-082026-08-14
TreatHSP Platform: Adaptive Natural History Platform for Ataxias, HSPs, and Spastic Ataxias
Hereditary Spastic Paraplegia, Spastic Ataxia
RecruitingHeidelberg University40002024-07-162026-09-01
D-Cycloserine for Serine Palmitoyltransferase Inhibition
D-cycloserine - Hereditary Spastic Paraplegia
Phase 4CompletedMassachusetts General Hospital12024-07-102026-04-21
Calcium Folinate Treatment of Spastic Paraplegia 56
calcium folinate - Hereditary Spastic Paraplegia
Early Phase 1RecruitingShanghai 6th People's Hospital102024-07-012024-06-27
Spastic Paraplegia - Centers of Excellence Research Network
Hereditary Spastic Paraplegia, Primary Lateral Sclerosis
RecruitingBoston Children's Hospital1002024-06-042026-03-18
12-Week Strength and Functional Exercise Program for Hereditary Spastic Paraplegia Trial (HSPMOVE)
Individualized Functional and Strength Exercises - Hereditary Spastic Paraplegia
Not applicableEnrolling by invitationHospital de Clinicas de Porto Alegre202024-04-272026-05-01
Evaluation of an Intensive Training Program for Patients with Hereditary Spastic Paraparesis SPG4/Spast
intensive reeducation - Hereditary Spastic Paraparesis
Not applicableRecruitingAssistance Publique - Hôpitaux de Paris502024-04-042024-11-25
Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology
Syde, Dynamometric measurements of muscle strength, The 6-minute walk test (6MWT) - Neuromuscular Diseases, Obesity (Disorder)
Not applicableRecruitingCentre Hospitalier Universitaire de Liege3002024-03-292025-08-22
STOP-HSP.Net: a Registry for Hereditary Spastic Paraplegia as an Integration Tool for Future Therapeutic Strategies
Hereditary Spastic Paraplegia
RecruitingIRCCS Fondazione Stella Maris5002024-01-242026-03-27
Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals
MTR-601 - Muscle Spasticity, Hypertonia, Muscle
Phase 1CompletedMotric Bio892023-09-112026-06-05
Natural History Study of Patients with HPDL Mutations
Patient Registry, Dry blood spots sampling - Mitochondrial Encephalomyopathies, Hereditary Spastic Paraplegia
RecruitingUniversity of California, San Diego502023-05-182025-03-30
The Effect of Targeting the Plantaris Muscle-tendon in Surgical Correction of Ankle Equinus in Children
Tendoachilles (TA) lengthening or gastrocnemius (GN) recession, then Plantaris tenotomy, Plantaris tenotomy, then Tendoachilles (TA) lengthening or gastrocnemius (GN) recession - Idiopathic Toe Walking, Cerebral Palsy
Not applicableRecruitingUniversity of Alberta422023-03-132026-03-12

Showing 20 of 49. Sign in to see all of them.

Narrower conditions

Motor Neuron Disease (9)  ·  Amyotrophic Lateral Sclerosis (6)  ·  Muscle Spasticity (6)  ·  Paraplegia (6)  ·  Neuromuscular Diseases (5)  ·  Muscular Atrophy, Spinal (4)  ·  Adrenoleukodystrophy (3)  ·  Cerebral Palsy (3)  ·  Charcot-Marie-Tooth Disease (3)  ·  Leukoencephalopathies (3)  ·  Spastic paraplegia 3, autosomal dominant (3)  ·  Adrenal Insufficiency (2)  ·  Brain Diseases, Metabolic (2)  ·  Brain Diseases, Metabolic, Inborn (2)

Broader conditions

Congenital Abnormalities (49)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (49)  ·  Hereditary Sensory and Motor Neuropathy (49)  ·  Nervous System Malformations (49)  ·  Peripheral Nervous System Diseases (49)  ·  Polyneuropathies (49)  ·  Nervous System Diseases (48)  ·  Genetic Diseases, Inborn (47)  ·  Heredodegenerative Disorders, Nervous System (47)  ·  Neurodegenerative Diseases (47)  ·  Neuromuscular Diseases (44)  ·  Central Nervous System Diseases (19)  ·  Neurologic Manifestations (16)  ·  Pathological Conditions, Signs and Symptoms (16)  ·  Brain Diseases (14)

Interventions

Physical Therapy Modalities (2)  ·  4-Aminopyridine (1)  ·  Atorvastatin (1)  ·  Blood Specimen Collection (1)  ·  Chenodeoxycholic Acid (1)  ·  Cycloserine (1)  ·  Extracorporeal Shockwave Therapy (1)  ·  Leucovorin (1)  ·  Pliability (1)  ·  Resveratrol (1)  ·  Spinal Cord Stimulation (1)  ·  Spinal Puncture (1)  ·  Walk Test (1)  ·  miglustat (1)

Sponsors

IRCCS Eugenio Medea (4)  ·  Assistance Publique - Hôpitaux de Paris (3)  ·  Boston Children's Hospital (3)  ·  IRCCS Fondazione Stella Maris (3)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (3)  ·  Shanghai 6th People's Hospital (3)  ·  University Hospital Tuebingen (3)  ·  Massachusetts General Hospital (2)  ·  Radboud University Medical Center (2)  ·  SwanBio Therapeutics, Inc. (2)  ·  University of Miami (2)  ·  BlackfinBio Ltd (1)  ·  Centre Hospitalier Universitaire de Liege (1)  ·  Dr. Rebecca Schule (1)  ·  European University of Lefke (1)

Countries

United States (17)  ·  Italy (9)  ·  Germany (7)  ·  China (5)  ·  France (5)  ·  Netherlands (5)  ·  Austria (2)  ·  Brazil (2)  ·  Canada (2)  ·  Poland (2)  ·  South Africa (2)  ·  Spain (2)  ·  Belgium (1)  ·  Cyprus (1)  ·  Czechia (1)

Top investigators

Filippo M Santorelli, MD PhD (2)  ·  Li Cao, phD (2)  ·  Michael Benatar, MD, PhD (2)  ·  Alan Hand, MD (1)  ·  Callyn Kirk, MSPH (1)  ·  Craig D Blackstone, M.D. (1)  ·  Darius Ebrahimi-Fakhari, MD, PhD (1)  ·  Elbrich Postma, PhD (1)  ·  Ferda Selcuk (1)  ·  Filippo M Santorelli, Dr. (1)  ·  Jakub M Antczak, MD (1)  ·  James D. Berry, MD, MPH (1)

Results publications

PMID 41491634, PMID 10540002, PMID 17030772, PMID 17364435, PMID 17709710, PMID 17980667, PMID 19833552, PMID 19922132, PMID 21706151, PMID 22507681, PMID 23421600, PMID 23944684, PMID 23952636, PMID 24067398, PMID 24070404, PMID 24778202, PMID 25054277, PMID 26205535, PMID 29228183, PMID 31214256, PMID 31646384, PMID 32139654, PMID 33101180, PMID 33413555, PMID 35472722, PMID 37804674, PMID 38058356, PMID 38291924, PMID 38557877, PMID 39185513, PMID 39270623, PMID 40040914, PMID 40368591, PMID 4056836, PMID 41199121, PMID 41667181, PMID 8229050, PMID 8302340, PMID 8423829, PMID 8639063, PMID 8858057

NIH funding

U54NS092091 (2), 2019 (1), 5RC1NS068179-02 (1), R01NS072248 (1), T32GM007748 (1), U01TR001263 (1)